Erika Vacchelli Selected Research

Erika Vacchelli Research Topics

Disease

68	Neoplasms (Cancer) 01/2023 - 01/2011
6	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 05/2012
6	Carcinoma (Carcinomatosis) 01/2023 - 09/2012
5	Breast Neoplasms (Breast Cancer) 01/2023 - 05/2012
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2019 - 05/2012
4	Carcinogenesis 01/2023 - 11/2012
3	Neoplasm Metastasis (Metastasis) 01/2023 - 11/2015
3	Necrosis 01/2013 - 01/2011
2	Inflammation (Inflammations) 01/2023 - 07/2012
2	Squamous Cell Carcinoma of Head and Neck 01/2022 - 01/2020
2	Obesity 11/2020 - 10/2020
2	Actinic Keratosis 01/2020 - 09/2012
2	Condylomata Acuminata (Genital Wart) 01/2020 - 09/2012
2	Lung Neoplasms (Lung Cancer) 11/2016 - 08/2012
2	Esophageal Neoplasms (Esophageal Cancer) 02/2016 - 08/2015
2	Prostatic Neoplasms (Prostate Cancer) 10/2013 - 10/2012
2	Multiple Sclerosis 03/2013 - 03/2012
2	Tuberculosis (Tuberculoses) 09/2012 - 08/2012
1	Colitis 01/2023
1	Ulcerative Colitis 01/2023
1	Hepatolenticular Degeneration (Wilson's Disease) 10/2020
1	Glucose Intolerance 10/2020
1	Infections 01/2020
1	Bites and Stings (Sting) 01/2020

Drug/Important Bio-Agent (IBA)

16	VaccinesIBA 01/2020 - 03/2012
12	AnthracyclinesIBA 01/2021 - 07/2012
12	Antineoplastic Agents (Antineoplastics)IBA 01/2014 - 01/2011
11	AntigensIBA 01/2020 - 10/2012
9	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019 - 03/2012
8	Adenosine Triphosphate (ATP)IBA 01/2019 - 12/2011
7	Monoclonal AntibodiesIBA 01/2015 - 01/2012
6	Peptides (Polypeptides)IBA 01/2023 - 12/2012
6	Pattern Recognition ReceptorsIBA 01/2022 - 05/2012
6	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 09/2012
6	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2019 - 03/2012
5	CytokinesIBA 01/2020 - 07/2012
5	Imiquimod (Aldara)FDA LinkGeneric 01/2020 - 08/2012
5	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 05/2012
5	Toll-Like Receptor AgonistsIBA 01/2014 - 08/2012
4	CarcinogensIBA 01/2021 - 06/2016
4	LigandsIBA 01/2021 - 01/2014
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2012
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2016 - 03/2012
3	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2021 - 11/2015
3	InterferonsIBA 01/2020 - 08/2015
3	HMGB1 Protein (HMG1)IBA 06/2016 - 03/2012
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2014 - 03/2012
3	Digoxin (Digitek)FDA LinkGeneric 02/2013 - 07/2012
2	Poly I-CIBA 01/2021 - 01/2020
2	Annexin A1IBA 01/2021 - 01/2019
2	Interferon Type IIBA 01/2020 - 11/2014
2	B7-H1 AntigenIBA 01/2020 - 01/2019
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020 - 08/2012
2	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2020 - 08/2012
2	CrizotinibIBA 04/2019 - 01/2019
2	AntibodiesIBA 01/2019 - 01/2012
2	SpermidineIBA 01/2019 - 11/2016
2	hydroxycitric acidIBA 01/2019 - 11/2016
2	Caspase 3 (Caspase-3)IBA 06/2016 - 03/2012
2	Hormones (Hormone)IBA 06/2016 - 10/2012
2	Therapeutic UsesIBA 11/2015 - 08/2012
2	monophosphoryl lipid AIBA 01/2014 - 08/2013
2	Protein Subunit VaccinesIBA 12/2013 - 12/2012
2	sipuleucel-T (APC8015)FDA Link 10/2013 - 10/2012
2	Immunomodulating AgentsIBA 09/2013 - 07/2012
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2013 - 05/2012
2	Purinergic Receptors (Receptors, Purine)IBA 04/2013 - 05/2012
2	Cardiac GlycosidesIBA 02/2013 - 12/2012
2	Vitamin B 6IBA 02/2013 - 08/2012
1	Phenobarbital (Luminal)FDA Link 01/2023
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2023
1	AzoxymethaneIBA 01/2023
1	MutagensIBA 01/2023
1	Detergents (Detergent)IBA 01/2023
1	Dextrans (Dextran)FDA Link 01/2023
1	Sulindac (Copal)FDA LinkGeneric 01/2023
1	cyclosporin HIBA 01/2023
1	PlatinumIBA 01/2022
1	Threonine (L-Threonine)FDA Link 01/2022
1	Alanine (L-Alanine)FDA Link 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2020
1	Trientine (Trien)FDA Link 10/2020
1	Chelating AgentsIBA 10/2020
1	CopperIBA 10/2020
1	Sucrose (Saccharose)IBA 10/2020
1	LeptinIBA 10/2020
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2020
1	Poly A-UIBA 01/2020
1	InterleukinsIBA 01/2020
1	resiquimodIBA 01/2020
1	VTX-2337IBA 01/2020
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020

Therapy/Procedure

31	Therapeutics 01/2020 - 01/2012
22	Drug Therapy (Chemotherapy) 01/2023 - 12/2011
5	Immunotherapy 01/2021 - 09/2012
4	Adjuvant Chemotherapy 06/2016 - 05/2012
3	Chemoradiotherapy 01/2023 - 08/2015
3	Radiotherapy 01/2020 - 09/2013
2	Caloric Restriction 01/2019 - 10/2016